Scientists at UC San Francisco have developed a powerful new cancer therapy that remains inactive until it reaches the brain, where it switches on to attack deadly tumors. The engineered immune cells, called B-SYNC CAR-T cells, completely eliminated diffuse midline glioma (DMG), an aggressive ch...

Source: [ScienceDaily](https://www.sciencedaily.com/releases/2026/11/261104084009.htm)

Sponsored